A pilot study of AL-1021 in chronic schizophrenic patients.
D000328:Adult; D002090:Butyrophenones / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D002090:Butyrophenones; D014149:Tranquilizing Agents